Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 193 to 199 of 199 entries
Sorted by: Best Match Show Resources per page
DNA repair genes polymorphisms and genetic susceptibility to Philadelphia-negative myeloproliferative neoplasms in a Portuguese population: The role of base excision repair genes polymorphisms.

Oncology letters

Azevedo AP, Silva SN, De Lima JP, Reichert A, Lima F, Júnior E, Rueff J.
PMID: 28599464
Oncol Lett. 2017 Jun;13(6):4641-4650. doi: 10.3892/ol.2017.6065. Epub 2017 Apr 21.

The role of base excision repair (BER) genes in Philadelphia-negative (PN)-myeloproliferative neoplasms (MPNs) susceptibility was evaluated by genotyping eight polymorphisms [apurinic/apyrimidinic endodeoxyribonuclease 1, mutY DNA glycosylase, earlier mutY homolog (

Cite
Azevedo AP, Silva SN, De Lima JP, et al. DNA repair genes polymorphisms and genetic susceptibility to Philadelphia-negative myeloproliferative neoplasms in a Portuguese population: The role of base excision repair genes polymorphisms. Oncol Lett. 2017;13(6):4641-4650doi: 10.3892/ol.2017.6065.
Azevedo, A. P., Silva, S. N., De Lima, J. P., Reichert, A., Lima, F., Júnior, E., & Rueff, J. (2017). DNA repair genes polymorphisms and genetic susceptibility to Philadelphia-negative myeloproliferative neoplasms in a Portuguese population: The role of base excision repair genes polymorphisms. Oncology letters, 13(6), 4641-4650. https://doi.org/10.3892/ol.2017.6065
Azevedo, Ana P, et al. "DNA repair genes polymorphisms and genetic susceptibility to Philadelphia-negative myeloproliferative neoplasms in a Portuguese population: The role of base excision repair genes polymorphisms." Oncology letters vol. 13,6 (2017): 4641-4650. doi: https://doi.org/10.3892/ol.2017.6065
Azevedo AP, Silva SN, De Lima JP, Reichert A, Lima F, Júnior E, Rueff J. DNA repair genes polymorphisms and genetic susceptibility to Philadelphia-negative myeloproliferative neoplasms in a Portuguese population: The role of base excision repair genes polymorphisms. Oncol Lett. 2017 Jun;13(6):4641-4650. doi: 10.3892/ol.2017.6065. Epub 2017 Apr 21. PMID: 28599464; PMCID: PMC5452988.
Copy Download .nbib Format: NLM
The interstellar chemistry of H.

Monthly notices of the Royal Astronomical Society

Loison JC, Agúndez M, Marcelino N, Wakelam V, Hickson KM, Cernicharo J, Gerin M, Roueff E, Guélin M.
PMID: 27013768
Mon Not R Astron Soc. 2016 Mar 11;456(4):4101-4110. doi: 10.1093/mnras/stv2866.

We present the detection of two H

Cite
Loison JC, Agúndez M, Marcelino N, et al. The interstellar chemistry of H. Mon Not R Astron Soc. 2016;456(4):4101-4110doi: 10.1093/mnras/stv2866.
Loison, J. C., Agúndez, M., Marcelino, N., Wakelam, V., Hickson, K. M., Cernicharo, J., Gerin, M., Roueff, E., & Guélin, M. (2016). The interstellar chemistry of H. Monthly notices of the Royal Astronomical Society, 456(4), 4101-4110. https://doi.org/10.1093/mnras/stv2866
Loison, Jean-Christophe, et al. "The interstellar chemistry of H." Monthly notices of the Royal Astronomical Society vol. 456,4 (2016): 4101-4110. doi: https://doi.org/10.1093/mnras/stv2866
Loison JC, Agúndez M, Marcelino N, Wakelam V, Hickson KM, Cernicharo J, Gerin M, Roueff E, Guélin M. The interstellar chemistry of H. Mon Not R Astron Soc. 2016 Mar 11;456(4):4101-4110. doi: 10.1093/mnras/stv2866. PMID: 27013768; PMCID: PMC4803190.
Copy Download .nbib Format: NLM
Healthcare provision for insect venom allergy patients during the COVID-19 pandemic.

Allergo journal international

Worm M, Ballmer-Weber B, Brehler R, Cuevas M, Gschwend A, Hartmann K, Hawranek T, Hötzenecker W, Homey B, Jakob T, Novak N, Pickert J, Saloga J, Schäkel K, Trautmann A, Treudler R, Wedi B, Sturm G, Rueff F.
PMID: 33312843
Allergo J Int. 2020;29(8):257-261. doi: 10.1007/s40629-020-00157-z. Epub 2020 Dec 08.

The population prevalence of insect venom allergy ranges between 3-5%, and it can lead to potentially life-threatening allergic reactions. Patients who have experienced a systemic allergic reaction following an insect sting should be referred to an allergy specialist for...

Cite
Worm M, Ballmer-Weber B, Brehler R, et al. Healthcare provision for insect venom allergy patients during the COVID-19 pandemic. Allergo J Int. 2020;29(8):257-261doi: 10.1007/s40629-020-00157-z.
Worm, M., Ballmer-Weber, B., Brehler, R., Cuevas, M., Gschwend, A., Hartmann, K., Hawranek, T., Hötzenecker, W., Homey, B., Jakob, T., Novak, N., Pickert, J., Saloga, J., Schäkel, K., Trautmann, A., Treudler, R., Wedi, B., Sturm, G., & Rueff, F. (2020). Healthcare provision for insect venom allergy patients during the COVID-19 pandemic. Allergo journal international, 29(8), 257-261. https://doi.org/10.1007/s40629-020-00157-z
Worm, Margitta, et al. "Healthcare provision for insect venom allergy patients during the COVID-19 pandemic." Allergo journal international vol. 29,8 (2020): 257-261. doi: https://doi.org/10.1007/s40629-020-00157-z
Worm M, Ballmer-Weber B, Brehler R, Cuevas M, Gschwend A, Hartmann K, Hawranek T, Hötzenecker W, Homey B, Jakob T, Novak N, Pickert J, Saloga J, Schäkel K, Trautmann A, Treudler R, Wedi B, Sturm G, Rueff F. Healthcare provision for insect venom allergy patients during the COVID-19 pandemic. Allergo J Int. 2020;29(8):257-261. doi: 10.1007/s40629-020-00157-z. Epub 2020 Dec 08. PMID: 33312843; PMCID: PMC7722411.
Copy Download .nbib Format: NLM
Consolidation nivolumab and ipilimumab versus observation in limited-disease small-cell lung cancer after chemo-radiotherapy - results from the randomised phase II ETOP/IFCT 4-12 STIMULI trial.

Annals of oncology : official journal of the European Society for Medical Oncology

Peters S, Pujol JL, Dafni U, Dómine M, Popat S, Reck M, Andrade J, Becker A, Moro-Sibilot D, Curioni-Fontecedro A, Molinier O, Nackaerts K, Insa Mollá A, Gervais R, López Vivanco G, Madelaine J, Mazieres J, Faehling M, Griesinger F, Majem M, González Larriba JL, Provencio Pulla M, Vervita K, Roschitzki-Voser H, Ruepp B, Mitchell P, Stahel RA, Le Pechoux C, De Ruysscher D.
PMID: 34562610
Ann Oncol. 2021 Sep 23; doi: 10.1016/j.annonc.2021.09.011. Epub 2021 Sep 23.

BACKGROUND: Concurrent chemotherapy and thoracic radiotherapy followed by prophylactic cranial irradiation (PCI) is the standard treatment in limited-disease small-cell lung cancer (LD-SCLC), with 5-year overall survival (OS) of only 25% to 33%.PATIENTS AND METHODS: STIMULI is a 1:1 randomised...

Cite
Peters S, Pujol JL, Dafni U, et al. Consolidation nivolumab and ipilimumab versus observation in limited-disease small-cell lung cancer after chemo-radiotherapy - results from the randomised phase II ETOP/IFCT 4-12 STIMULI trial. Ann Oncol. 2021;doi: 10.1016/j.annonc.2021.09.011.
Peters, S., Pujol, J. L., Dafni, U., Dómine, M., Popat, S., Reck, M., Andrade, J., Becker, A., Moro-Sibilot, D., Curioni-Fontecedro, A., Molinier, O., Nackaerts, K., Insa Mollá, A., Gervais, R., López Vivanco, G., Madelaine, J., Mazieres, J., Faehling, M., Griesinger, F., Majem, M., González Larriba, J. L., Provencio Pulla, M., Vervita, K., Roschitzki-Voser, H., Ruepp, B., Mitchell, P., Stahel, R. A., Le Pechoux, C., De Ruysscher, D. (2021). Consolidation nivolumab and ipilimumab versus observation in limited-disease small-cell lung cancer after chemo-radiotherapy - results from the randomised phase II ETOP/IFCT 4-12 STIMULI trial. Annals of oncology : official journal of the European Society for Medical Oncology, . https://doi.org/10.1016/j.annonc.2021.09.011
Peters, S, et al. "Consolidation nivolumab and ipilimumab versus observation in limited-disease small-cell lung cancer after chemo-radiotherapy - results from the randomised phase II ETOP/IFCT 4-12 STIMULI trial." Annals of oncology : official journal of the European Society for Medical Oncology vol. (2021). doi: https://doi.org/10.1016/j.annonc.2021.09.011
Peters S, Pujol JL, Dafni U, Dómine M, Popat S, Reck M, Andrade J, Becker A, Moro-Sibilot D, Curioni-Fontecedro A, Molinier O, Nackaerts K, Insa Mollá A, Gervais R, López Vivanco G, Madelaine J, Mazieres J, Faehling M, Griesinger F, Majem M, González Larriba JL, Provencio Pulla M, Vervita K, Roschitzki-Voser H, Ruepp B, Mitchell P, Stahel RA, Le Pechoux C, De Ruysscher D. Consolidation nivolumab and ipilimumab versus observation in limited-disease small-cell lung cancer after chemo-radiotherapy - results from the randomised phase II ETOP/IFCT 4-12 STIMULI trial. Ann Oncol. 2021 Sep 23; doi: 10.1016/j.annonc.2021.09.011. Epub 2021 Sep 23. PMID: 34562610.
Copy Download .nbib Format: NLM
First detection of doubly deuterated methyl acetylene (CHD.

Astronomy and astrophysics

Agúndez M, Roueff E, Cabezas C, Cernicharo J, Marcelino N.
PMID: 34334795
Astron Astrophys. 2021 Jun 01;649. doi: 10.1051/0004-6361/202140843. eCollection 2021 May.

We report the first detection in space of the two doubly deuterated isotopologues of methyl acetylene. The species CHD

Cite
Agúndez M, Roueff E, Cabezas C, et al. First detection of doubly deuterated methyl acetylene (CHD. Astron Astrophys. 2021;649doi: 10.1051/0004-6361/202140843.
Agúndez, M., Roueff, E., Cabezas, C., Cernicharo, J., & Marcelino, N. (2021). First detection of doubly deuterated methyl acetylene (CHD. Astronomy and astrophysics, 649. https://doi.org/10.1051/0004-6361/202140843
Agúndez, M, et al. "First detection of doubly deuterated methyl acetylene (CHD." Astronomy and astrophysics vol. 649 (2021). doi: https://doi.org/10.1051/0004-6361/202140843
Agúndez M, Roueff E, Cabezas C, Cernicharo J, Marcelino N. First detection of doubly deuterated methyl acetylene (CHD. Astron Astrophys. 2021 Jun 01;649. doi: 10.1051/0004-6361/202140843. eCollection 2021 May. PMID: 34334795; PMCID: PMC7611416.
Copy Download .nbib Format: NLM
Pretherapeutic screening for Dihydropyrimidine deshydrogenase deficiency in measuring uracilemia in dialysis patients leads to a high rate of falsely positive results.

Cancer chemotherapy and pharmacology

Gaible C, Narjoz C, Loriot MA, Roueff S, Pallet N.
PMID: 34515833
Cancer Chemother Pharmacol. 2021 Dec;88(6):1049-1053. doi: 10.1007/s00280-021-04354-7. Epub 2021 Sep 13.

BACKGROUND: Pretherapeutic screening for dihydropyrimidine dehydrogenase (DPD) deficiency is recommended prior to the administration of fluoropyrimidine-based chemotherapy. However, the best strategy to identify DPD deficiency in End Stage Renal Disease (ESRD) patients is unknown.METHODS: We assessed the characteristics of...

Cite
Gaible C, Narjoz C, Loriot MA, et al. Pretherapeutic screening for Dihydropyrimidine deshydrogenase deficiency in measuring uracilemia in dialysis patients leads to a high rate of falsely positive results. Cancer Chemother Pharmacol. 2021;88(6):1049-1053doi: 10.1007/s00280-021-04354-7.
Gaible, C., Narjoz, C., Loriot, M. A., Roueff, S., & Pallet, N. (2021). Pretherapeutic screening for Dihydropyrimidine deshydrogenase deficiency in measuring uracilemia in dialysis patients leads to a high rate of falsely positive results. Cancer chemotherapy and pharmacology, 88(6), 1049-1053. https://doi.org/10.1007/s00280-021-04354-7
Gaible, Clotilde, et al. "Pretherapeutic screening for Dihydropyrimidine deshydrogenase deficiency in measuring uracilemia in dialysis patients leads to a high rate of falsely positive results." Cancer chemotherapy and pharmacology vol. 88,6 (2021): 1049-1053. doi: https://doi.org/10.1007/s00280-021-04354-7
Gaible C, Narjoz C, Loriot MA, Roueff S, Pallet N. Pretherapeutic screening for Dihydropyrimidine deshydrogenase deficiency in measuring uracilemia in dialysis patients leads to a high rate of falsely positive results. Cancer Chemother Pharmacol. 2021 Dec;88(6):1049-1053. doi: 10.1007/s00280-021-04354-7. Epub 2021 Sep 13. PMID: 34515833.
Copy Download .nbib Format: NLM
[No title available]

Allergo Journal : interdisziplinare Zeitschrift fur Allergologie und Umweltmedizin : Organ der Deutschen Gesellschaft fur Allergie- und Immunitatsforschung

Worm M, Ballmer-Weber B, Brehler R, Cuevas M, Gschwend A, Hartmann K, Hawranek T, Hötzenecker W, Homey B, Jakob T, Novak N, Pickert J, Saloga J, Schäkel K, Trautmann A, Treudler R, Wedi B, Sturm G, Rueff F.
PMID: 33343095
Allergo J. 2020;29(8):16-21. doi: 10.1007/s15007-020-2646-7. Epub 2020 Dec 18.

No abstract available.

Cite
Worm M, Ballmer-Weber B, Brehler R, et al. Versorgungssituation von Insektengiftallergikern während der COVID-19-Pandemie. . Allergo J. 2020;29(8):16-21doi: 10.1007/s15007-020-2646-7.
Worm, M., Ballmer-Weber, B., Brehler, R., Cuevas, M., Gschwend, A., Hartmann, K., Hawranek, T., Hötzenecker, W., Homey, B., Jakob, T., Novak, N., Pickert, J., Saloga, J., Schäkel, K., Trautmann, A., Treudler, R., Wedi, B., Sturm, G., & Rueff, F. (2020). Versorgungssituation von Insektengiftallergikern während der COVID-19-Pandemie. . Allergo Journal : interdisziplinare Zeitschrift fur Allergologie und Umweltmedizin : Organ der Deutschen Gesellschaft fur Allergie- und Immunitatsforschung, 29(8), 16-21. https://doi.org/10.1007/s15007-020-2646-7
Worm, Margitta, et al. "Versorgungssituation von Insektengiftallergikern während der COVID-19-Pandemie." . Allergo Journal : interdisziplinare Zeitschrift fur Allergologie und Umweltmedizin : Organ der Deutschen Gesellschaft fur Allergie- und Immunitatsforschung vol. 29,8 (2020): 16-21. doi: https://doi.org/10.1007/s15007-020-2646-7
Worm M, Ballmer-Weber B, Brehler R, Cuevas M, Gschwend A, Hartmann K, Hawranek T, Hötzenecker W, Homey B, Jakob T, Novak N, Pickert J, Saloga J, Schäkel K, Trautmann A, Treudler R, Wedi B, Sturm G, Rueff F. Versorgungssituation von Insektengiftallergikern während der COVID-19-Pandemie. . Allergo J. 2020;29(8):16-21. doi: 10.1007/s15007-020-2646-7. Epub 2020 Dec 18. German. PMID: 33343095; PMCID: PMC7735182.
Copy Download .nbib Format: NLM
Showing 193 to 199 of 199 entries